What Are Antibody Drugs?
Antibody drugs, often referred to as therapeutic antibodies, represent a transformative class of treatments in modern medicine. These specialized proteins are engineered to target specific antigens as...
What is the Difference Between Macromolecules and Small Molecules?
MacromoleculesMacromolecules are those with super large molecular weights. The relative molecular mass is usually above 5,000, and can even soar to more than one million, such as proteins, nucleic aci...
How AI Revolutionizes Drug Development
In March 2016, the AI program AlphaGo defeated the Korean Go master Lee Sedol, marking a pivotal moment in AI development. This breakthrough not only thrilled the tech world but also ignited hope in t...
What are Bispecific Antibodies and Their Therapeutic Potential?
Bispecific antibodies (BsAbs) are a class of engineered antibodies designed to bind to two distinct antigens simultaneously, setting them apart from monoclonal antibodies in the comparison of monoclon...
Monoclonal vs. Bispecific Antibodies
In the rapidly evolving world of biotechnology, antibodies have become powerhouse tools in fighting diseases like cancer, autoimmune disorders, and infections. But what sets monoclonal antibodies (mAb...
Quality Assurance and Quality Control in Pharmaceutical Company
Within the pharmaceutical industry, quality assurance and quality control are terms often used interchangeably because both are integral to quality management and fulfilling customer expectations. The...
AI in Antibody Discovery
The pharmaceutical industry is experiencing a transformative shift, driven by AI-based drug discovery in the realm of biologics. Biologics, complex therapies derived from living organisms, hold immens...
Zhongguancun FIC Alliance for Global Strategic Development of Innovative Drugs is established to help China break through the global of innovative drugs
On September 24, the "Zhongguancun FIC Alliance for Global Strategic Development of Innovative Drugs", co-sponsored by a number of industry leading institutions and enterprises such as Hotge...
A major breakthrough! A phase Ib clinical study of SGC001, a “global pioneer” antibody drug for acute myocardial infarction by Sungen, has achieved positive results
Recently, a phase Ib clinical study of SGC001 Injection, the world's first antibody drug for acute myocardial infarction, developed by Sungen, has obtained positive preliminary results. The data s...
